Differential diagnosis of coma or sedation of unknown origin (to check if benzodiazepine involvement exists) --- Dosage (Adults): Initial dose: 0.2 mg IV over 15 seconds If no response, give 0.3 mg after 30 seconds May repeat 0.5 mg every 30 seconds up to a total of 3 mg (occasionally 5 mg if needed) --- Side Effects: Nausea and vomiting Dizziness Agitation or anxiety Headache Seizures (especially in patients dependent on benzodiazepines or co-ingesting tricyclic antidepressants) Arrhythmias (rare) --- Contraindications: Hypersensitivity to flumazenil Chronic benzodiazepine users (can trigger withdrawal and seizures) Patients with seizure disorders treated with benzodiazepines Mixed drug overdose (especially tricyclic antidepressants) --- Precautions: Continuous monitoring required for respiration and consciousness Risk of re-sedation after initial reversal due to flumazenils short half-life Use cautiously in hepatic impairment --- Storage: Store below 25C, protected from light

Conversely, among those between the ages of 30 and 49, women are more than twice as likely to have used a GLP-1 agonist than their male peers. Sources RAND, news release and study, Aug
Female-specific research remains limited relative to the broader literature on IGF-1 LR3
Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1.9 million people
Additionally, the body must rely on liver detoxification to get rid of it
HSF2 is primarily involved in organismal developmental differentiation and acts in concert with HSF1 during spermatogenesis (Singh et al., 2024b)